KINDERIntervention Test for Preventing Elder Abuse in Family Caregiving
This clinical trial is a phase 2 interventional study that aims to prevent elder abuse in family caregiving. It will assess the impact of the intervention on psychological elder abuse and quality of caregiving using modified scales and surveys.
Knowledge and Interpersonal Skills to Develop Enhanced Relationships
+ Healthy Living for the Caregiver
Mental Disorders+3
+ Brain Diseases
+ Central Nervous System Diseases
Prevention Study
Summary
Study start date: March 11, 2026
Actual date on which the first participant was enrolled.This study focuses on preventing psychological elder abuse in family caregiving situations, particularly for those caring for individuals living with dementia. The intervention, known as KINDER (Knowledge and Interpersonal Skills to Develop Enhanced Relationships), aims to improve the quality of caregiving by reducing stress in the caregiver-care recipient relationship and enhancing the caregiver's ability to handle challenges. This research is important as it seeks to address and prevent potential emotional harm to elderly individuals, ensuring they receive respectful and compassionate care from family members. Participants in the study will be part of a trial where they are randomly assigned to either receive the KINDER intervention or be part of a control group. The intervention focuses on building skills and knowledge that help caregivers manage their responsibilities more effectively. The study evaluates the impact of the intervention on reducing psychological harm, aiming to report on the effectiveness of the KINDER approach. Although specific risks or benefits are not detailed, the overall goal is to foster better caregiving environments and relationships.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.260 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * Family member, including family of choice, to an individual living with AD/ADRD * Is aged 18 years or older; * Provides assistance with at least two instrumental activities of daily living or one activity of daily living; * Provides at least 4 hours of caregiving per day * The care recipient is at least age 65 or older * The care recipient has early or mid-stage AD/ADRD, as indicated by a score of 4 to 6 on the Global Deterioration Scale Exclusion Criteria: * Sees the care recipient in-person less than 2 times per week * Has plans to place the care recipient in a skilled nursing facility within the next 8 months
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location